Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.

Prince Court Medical Centre provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 2007, the MSQH accredited hospital is based in Kuala Lumpur, Malaysia, with 277 beds and services for domestic and international patients.
The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.
At Parkway Pantai, patients can access comprehensive Cholangiocarcinoma Treatment supported by advanced diagnostic, surgical, and oncology facilities. Established in 1974, the JCI, MSQH accredited hospital is located in Kuala Lumpur, Malaysia, and has 499 beds.
Bile duct cancer treatment is personalised according to the tumour's location, stage, and overall health of the patient. Potentially operable tumours may be treated with surgery, while patients with advanced disease may receive systemic therapies such as chemotherapy, targeted medicines, or immunotherapy. Biliary drainage or stenting may also be used to relieve obstruction when required.
Sunway Medical Centre offers specialised Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern surgical and medical oncology technologies and established treatment protocols. Established in 1999, the ACHS accredited hospital is situated in Kuala Lumpur, Malaysia, with 724 beds, serving local and international patients.
Treatment may include surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, or biliary drainage procedures, depending on the cancer's location and stage. Molecular testing may identify specific alterations that could make targeted treatment appropriate. Before therapy, specialists conduct comprehensive imaging, pathology, staging, and liver-function assessments to develop an individualised treatment plan.
ParkCity Medical Centre provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 2012, the JCI accredited hospital is based in Kuala Lumpur, Malaysia, with 300 beds and services for domestic and international patients.
The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.
Subang Jaya Medical Centre offers advanced Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern oncology and hepatobiliary surgery techniques and internationally accepted treatment protocols. Established in 1985, the JCI accredited hospital is located in Kuala Lumpur, Malaysia, with 442 beds, providing comprehensive cancer care for local and international patients.
Treatment depends on the location, stage, and extent of the bile duct cancer. Surgery may be considered for tumours that can be completely removed, while advanced disease may require chemotherapy, targeted therapy, immunotherapy, or radiation therapy. Detailed imaging, tissue diagnosis, and molecular testing may help specialists determine the most appropriate treatment approach.
Ara Damansara Medical Centre offers advanced Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern oncology and hepatobiliary surgery techniques and internationally accepted treatment protocols. Established in 2012, the JCI, MSQH accredited hospital is located in Kuala Lumpur, Malaysia, with 220 beds, providing comprehensive cancer care for local and international patients.
Treatment depends on the location, stage, and extent of the bile duct cancer. Surgery may be considered for tumours that can be completely removed, while advanced disease may require chemotherapy, targeted therapy, immunotherapy, or radiation therapy. Detailed imaging, tissue diagnosis, and molecular testing may help specialists determine the most appropriate treatment approach.
At Beverly Wilshire Medical Centre, patients can access comprehensive Cholangiocarcinoma Treatment supported by advanced diagnostic, surgical, and oncology facilities. Established in 2012, the ISO accredited hospital is located in Kuala Lumpur, Malaysia, and it has adequate bed capacity.
Bile duct cancer treatment is personalised according to the tumour's location, stage, and overall health of the patient. Potentially operable tumours may be treated with surgery, while patients with advanced disease may receive systemic therapies such as chemotherapy, targeted medicines, or immunotherapy. Biliary drainage or stenting may also be used to relieve obstruction when required.
Bukit Tinggi Medical Centre offers specialised Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern surgical and medical oncology technologies and established treatment protocols. Established in 2016, the MSQH accredited hospital is situated in Kuala Lumpur, Malaysia, with 171 beds, serving local and international patients.
Treatment may include surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, or biliary drainage procedures, depending on the cancer's location and stage. Molecular testing may identify specific alterations that could make targeted treatment appropriate. Before therapy, specialists conduct comprehensive imaging, pathology, staging, and liver-function assessments to develop an individualised treatment plan.

Monica from Ghana suffered from AV malformation. She decided to look for options for medical treatment when she started experiencing episodes of unconsciousness. After a…

Nasrin (Sister of the patient ) explains the journey of how MediGence helped for the treatment of Silim Shabani for Ovarian Cancer Treatment in Turkey.